EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Specific gut microbiota alterations and metabolic deficits in Parkinson’s disease: a controlled comparison with functional constipation

Shuang Yang, Chen Tian, Ding Peng

Frontiers in Cellular and Infection Microbiology · 28.05.2026 · 16

DOI: 10.3389/fcimb.2026.1767241 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.05.2026. Verfasst von Shuang Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xuanwu Hospital Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Constipation, Parkinson Disease, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To isolate Parkinson’s disease (PD)-specific gut dysbiosis from motility-related changes, this study compared the fecal microbiota of PD patients with constipation (PDC, n=20) against a functional constipation (FC, n=15) control group.

Methods

High-throughput 16S rRNA gene sequencing and functional prediction were performed on fecal samples. Diversity metrics and taxonomic compositions were analyzed to identify PD-specific signatures.

Results

The PDC group exhibited significantly higher microbial richness than the FC group (P = 0.01). Despite structural similarities driven by the shared constipation phenotype (ANOSIM R = 0.084), PDC was distinguished by specific compositional shifts, including the enrichment of Paraprevotella , Akkermansia , unclassified Ruminococcaceae , and Campylobacter . Functionally, the PDC microbiome showed significant deficits in tyrosine and glutathione metabolism pathways (P<0.05), indicating compromised dopamine precursor synthesis and antioxidant defense.

Conclusion

By controlling for colonic transit time, this study identified specific microbial alterations and metabolic deficits in PD independent of constipation. These findings support a “gut-first” etiology linked to specific pathobionts and barrier compromise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationParkinson DiseaseGastrointestinal MicrobiomeDysbiosisBacteriaHumansRNA, Ribosomal, 16SFecesMaleFemaleAgedSequence Analysis, DNADNA, BacterialGlutathioneHigh-Throughput Nucleotide SequencingDNA, Ribosomal

Stichwörter der Autor:innen

16S rRNA sequencingParkinson’s diseasefunctional constipationgut microbiotagut-brain axis

Substanzen

RNA, Ribosomal, 16SDNA, BacterialGlutathioneDNA, Ribosomal

Autor:innen und Institutionen

  • Department of Gastroenterology, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Department of Respiratory and Critical Care Medicine, Beijing Haidian Hospital, Beijing, China.

Zitieren

APA

Yang, S., Tian, C., & Peng, D. (2026). Specific gut microbiota alterations and metabolic deficits in Parkinson’s disease: a controlled comparison with functional constipation. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1767241

Vancouver

Yang S, Tian C, Peng D. Specific gut microbiota alterations and metabolic deficits in Parkinson’s disease: a controlled comparison with functional constipation. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1767241

BibTeX
@article{Yang2026,
  author = {Yang, Shuang and Tian, Chen and Peng, Ding},
  title = {Specific gut microbiota alterations and metabolic deficits in Parkinson’s disease: a controlled comparison with functional constipation},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1767241}
}
Kostenlos starten →